↓ Skip to main content

Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

Overview of attention for article published in BMC Cancer, October 2010
Altmetric Badge

Mentioned by

patent
1 patent

Citations

dimensions_citation
130 Dimensions

Readers on

mendeley
39 Mendeley
citeulike
2 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma
Published in
BMC Cancer, October 2010
DOI 10.1186/1471-2407-10-524
Pubmed ID
Authors

Nina Wagener, Stephan Macher-Goeppinger, Maria Pritsch, Johannes Hüsing, Karin Hoppe-Seyler, Peter Schirmacher, Jesco Pfitzenmaier, Axel Haferkamp, Felix Hoppe-Seyler, Markus Hohenfellner

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 39 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 3%
Unknown 38 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 31%
Student > Ph. D. Student 9 23%
Student > Bachelor 5 13%
Student > Master 4 10%
Student > Postgraduate 2 5%
Other 2 5%
Unknown 5 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 14 36%
Biochemistry, Genetics and Molecular Biology 8 21%
Medicine and Dentistry 6 15%
Chemistry 3 8%
Unspecified 1 3%
Other 0 0%
Unknown 7 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 September 2014.
All research outputs
#7,610,424
of 23,204,238 outputs
Outputs from BMC Cancer
#2,110
of 8,417 outputs
Outputs of similar age
#35,598
of 99,982 outputs
Outputs of similar age from BMC Cancer
#16
of 48 outputs
Altmetric has tracked 23,204,238 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,417 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 99,982 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 24th percentile – i.e., 24% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 48 others from the same source and published within six weeks on either side of this one. This one is in the 27th percentile – i.e., 27% of its contemporaries scored the same or lower than it.